AC01 not checked

AnaCardio AB

FollowEvery change as it happens, and a Monday email
Stage
 
Next date
Phase 2 trial completes
Trials
1 active
2 in total · 2 in the EU
Targets
—
None known yet

What this is

How it works
How it works isn't classified yet
Tested for
Heart Failure With Reduced Ejection Fraction (HFrEF)
Main trialPhase 2
“The primary purpose of the study is to evaluate the safety and efficacy of 2 doses of AC01 compared to placebo over 12 weeks in participants with chronic advanced HFrEF.”In the company’s words, NCT07584967 on ClinicalTrials.gov

Other drugs for Heart Failure With Reduced Ejection Fraction (HFrEF)

All 42 drugs for Heart Failure With Reduced Ejection Fraction (HFrEF)

Coming up1

Changes1

Last 90 days

Trials2

TrialPhaseCompletesWhat it tests
Phase 2Recruiting 30 Jul 2028 A Study to Evaluate the Safety and Efficacy of AC01 Compared to Placebo in Participants With Chronic Heart Failure
Phase 1/2Completed 27 Oct 2025 Phase Ib/IIa Trial With AC01 in Patients With HFrEF
A trial in both registries shows both numbers.

About

Sources
ClinicalTrials.gov updated 19 Nov 2026 · EU trials register (CTIS) updated 19 Nov 2026 · openFDA updated 19 Nov 2026

Follow AC01

Following is part of Solo: you see every change to AC01 the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in